{"product_id":"resmed-marketing-mix","title":"ResMed Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGet Inspired by a Complete Brand Strategy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eResMed’s marketing mix blends innovative CPAP and digital health products, premium pricing aligned with clinical value, omnichannel distribution through healthcare partners and direct sales, and targeted promotion emphasizing outcomes and clinician trust—discover the strategic levers behind its market leadership in the full 4P’s report, ready-made and editable for presentations, benchmarking, or strategy work.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNext-Generation AirSense Series Devices\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eResMed’s Next-Generation AirSense devices build on the AirSense 11 platform with integrated cellular connectivity and AI algorithms that raised adherence rates: clinical pilots in 2024 showed nightly use up 8% and 30-day retention up 12% versus legacy models.\u003c\/p\u003e\n\u003cp\u003eDevices auto-adjust pressure per-breath, delivering real-time feedback via myAir and reducing residual AHI by ~25% in cohort studies; firmware updates pushed over-the-air quarterly in 2025.\u003c\/p\u003e\n\u003cp\u003eBy end-2025 the hardware shrank 18% in volume and noise fell to 20 dBA, improving comfort and discretion and supporting broader home-initiation programs tied to recurring revenue.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Mask and Interface Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eResMed’s Advanced mask and interface portfolio includes nasal, pillows, and full-face masks such as the AirFit series, engineered for high seal and low skin irritation; AirFit accounted for roughly 28% of mask unit sales in FY2024, per company disclosures. Continuous materials innovation produced lighter, more flexible frames in 2023–24, improving fit across facial types and sleep positions. Consumables drive recurring revenue—mask and cushion replacements generated about US$820 million in FY2024, sustaining long-term patient engagement.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSaaS and Digital Health Ecosystem\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eResMed’s SaaS and digital health ecosystem—AirView and myAir—powers remote patient monitoring for over 6.5 million users and supports ~40,000 provider sites, letting clinicians triage patients who need immediate intervention or coaching.\u003c\/p\u003e\n\u003cp\u003eCloud platforms cut clinic follow-up time by ~30% and, as of 2025, integrated generative AI delivers personalized sleep coaching and predictive insights that ResMed reports reduce therapy dropout rates by ~18%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVentilation and Respiratory Care Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eResMed extends beyond sleep apnea with ventilators and bilevels like Astral and Stellar, targeting COPD and chronic respiratory care and generating an estimated $1.2B in ventilator-related revenue in 2024.\u003c\/p\u003e\n\u003cp\u003eThese devices support hospital-to-home workflows with portable, battery-backed life support, boosting post-acute revenue and reducing LOS (length of stay) by ~12% in published studies.\u003c\/p\u003e\n\u003cp\u003eThe focus on high-acuity respiratory care helps ResMed capture a larger chronic disease market and diversify away from CPAP dependence.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eAstral\/Stellar lines: hospital-to-home ventilators\u003c\/li\u003e\n\u003cli\u003e2024 ventilator revenue ≈ $1.2B\u003c\/li\u003e\n\u003cli\u003eSupports COPD, neuromuscular disease, high-acuity care\u003c\/li\u003e\n\u003cli\u003ePortable\/battery life-support reduces LOS ~12%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDiagnostic and Screening Technologies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eResMed’s home sleep testing kits and digital screening tools simplify diagnosis for the ~1 billion people with sleep apnea worldwide; HST adoption cut time-to-diagnosis by ~40% in 2024 studies, expanding referral flow from primary care into ResMed’s device funnel.\u003c\/p\u003e\n\u003cp\u003eThese tools integrate with electronic health records and telehealth workflows, letting PCPs screen and refer remotely, reducing reliance on sleep labs and capturing a larger addressable market worth an estimated $3.5B in device and cloud revenue by 2025.\u003c\/p\u003e\n\u003cp\u003eHere’s the quick math: faster HST + PCP integration → higher referrals + lower lab costs, so ResMed increases device uptake and recurring cloud revenue.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHST adoption cut diagnosis time ~40% (2024)\u003c\/li\u003e\n\u003cli\u003e~1B people estimated with sleep apnea globally\u003c\/li\u003e\n\u003cli\u003eAddressable device\/cloud market ≈ $3.5B by 2025\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResMed: AI devices, 6.5M SaaS users, $820M consumables \u0026amp; $3.5B device\/cloud market\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eResMed’s product mix centers on AI-enabled AirSense devices, AirFit masks (28% unit share FY2024), SaaS platforms (6.5M users, ~40k sites), ventilators (~$1.2B 2024 revenue) and HST kits (diagnosis time −40% 2024), driving recurring consumables ~$820M FY2024 and estimated addressable device\/cloud market ~$3.5B by 2025.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eItem\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAirSense adherence uplift\u003c\/td\u003e\n\u003ctd\u003eNightly +8%, 30-day +12% (2024 pilots)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAirFit masks\u003c\/td\u003e\n\u003ctd\u003e28% unit share FY2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConsumables\u003c\/td\u003e\n\u003ctd\u003e$820M revenue FY2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSaaS users\/sites\u003c\/td\u003e\n\u003ctd\u003e6.5M users, 40k sites\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVentilators\u003c\/td\u003e\n\u003ctd\u003e$1.2B revenue 2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHST impact\u003c\/td\u003e\n\u003ctd\u003eDiagnosis time −40% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMarket\u003c\/td\u003e\n\u003ctd\u003e$3.5B device\/cloud by 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a concise, company-specific deep dive into ResMed’s Product, Price, Place, and Promotion strategies, ideal for managers and consultants needing a clear marketing positioning breakdown grounded in real brand practices and competitive context.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses ResMed’s 4P marketing insights into a concise, leadership-ready summary that highlights product, pricing, placement, and promotion as practical pain relievers for patient adherence and provider adoption.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHome Medical Equipment Distribution Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eResMed’s primary channel is an extensive network of Home Medical Equipment (HME) and Durable Medical Equipment (DME) partners that handle patient setup, local insurance claims, and parts logistics; in 2024 these channels contributed roughly 48% of ResMed’s device revenue (company filings).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect-to-Consumer E-commerce Platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eResMed sells direct-to-consumer via branded online stores and authorized e-retailers, driving global DTC revenue that grew ~18% in 2024 to an estimated $700M, mainly from masks, filters, and accessories.\u003c\/p\u003e\n\u003cp\u003eThis channel fits tech-savvy buyers who prefer home delivery—online masks\/accessories orders rose ~22% YoY in 2024—cutting distribution time by ~30% versus some retail partners.\u003c\/p\u003e\n\u003cp\u003eDirect sales let ResMed collect purchase and loyalty data across ages and regions; ResMed reported DTC customer repeat-buy rates near 45% in 2024, aiding targeted retention and product development.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInstitutional and Hospital Sales Channels\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eResMed deploys a specialized sales force to serve hospitals, sleep clinics, and long-term care facilities, focusing on high-acuity ventilators and diagnostic systems that need clinical oversight; institutional sales were ~24% of FY2025 revenue, about $1.4B. \u003c\/p\u003e\n\u003cp\u003eThese channels place ventilators and cloud-connected diagnostics integrated with EHRs, reducing deployment time by ~30% in pilot programs and improving follow-up adherence. \u003c\/p\u003e\n\u003cp\u003eBy winning contracts with major systems—ResMed reported agreements covering 18 of the top 50 US health systems in 2025—the company secures product placement at discharge, boosting device lifetime revenue and recurring cloud service fees. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational Subsidiary and Distributor Presence\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eResMed operates in over 140 countries through direct subsidiaries in major markets (United States, Australia, Europe) and local distributors in emerging regions, balancing control and reach.\u003c\/p\u003e\n\u003cp\u003eThis multi-tiered approach helps navigate local regulations and cultural healthcare nuances, reducing compliance risk and improving adoption in markets like Brazil and India.\u003c\/p\u003e\n\u003cp\u003eIn 2025 ResMed is localizing supply chains and distribution hubs—cutting average lead times by ~15% and lowering logistics disruption exposure after 2022–24 shocks.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e140+ countries coverage\u003c\/li\u003e\n\u003cli\u003eDirect subsidiaries in US, Australia, Europe\u003c\/li\u003e\n\u003cli\u003eLocal distributors for emerging markets\u003c\/li\u003e\n\u003cli\u003e2025 supply-chain localization, ~15% faster delivery\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCloud-Based Digital Distribution\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eResMed delivers software via a global cloud infrastructure, making digital health tools accessible to clinicians and patients in 140+ countries and syncing data in real time.\u003c\/p\u003e\n\u003cp\u003eCloud delivery enables instantaneous updates and secure data sync, removing physical barriers to therapy management and improving adherence; ResMed reported 2024 connected-device revenue growth of ~18% YoY.\u003c\/p\u003e\n\u003cp\u003eScalable cloud services link home devices to clinicians, supporting over 10 million cloud-connected patients and reducing follow-up burden through remote monitoring.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eGlobal reach: 140+ countries\u003c\/li\u003e\n\u003cli\u003eReal-time sync: instantaneous updates\u003c\/li\u003e\n\u003cli\u003eScale: 10M+ connected patients\u003c\/li\u003e\n\u003cli\u003eFinancial: ~18% YoY connected-device revenue growth (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResMed: $2.1B+ sales, 10M+ connected patients, DTC +18% and 15% faster supply chain\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eResMed uses HME\/DME partners (≈48% device revenue 2024), DTC e-commerce (~$700M, +18% YoY 2024), institutional sales (~$1.4B, 24% FY2025), and global cloud delivery (10M+ connected patients, +18% connected-device rev 2024) across 140+ countries, with 2025 supply-chain localization cutting lead times ~15%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHME\/DME share\u003c\/td\u003e\n\u003ctd\u003e~48% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDTC revenue\u003c\/td\u003e\n\u003ctd\u003e$700M (+18% 2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInstitutional sales\u003c\/td\u003e\n\u003ctd\u003e$1.4B (24% FY2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConnected patients\u003c\/td\u003e\n\u003ctd\u003e10M+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConnected-device growth\u003c\/td\u003e\n\u003ctd\u003e+18% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGeographic reach\u003c\/td\u003e\n\u003ctd\u003e140+ countries\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSupply-chain lead time cut\u003c\/td\u003e\n\u003ctd\u003e~15% (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eResMed 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the actual, full ResMed 4P's Marketing Mix analysis you’ll receive instantly after purchase—no samples or mockups, just the ready-made, editable document ready for immediate use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56750113554809,"sku":"resmed-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/resmed-marketing-mix.png?v=1772222226","url":"https:\/\/matrixbcg.com\/products\/resmed-marketing-mix","provider":"MatrixBCG","version":"1.0","type":"link"}